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Abstract:  
Aims: Acute mountain sickness (AMS) develops when the body fails to acclimatize to atmospheric 
changes at altitude. Pre-ascent prediction of susceptibility to AMS would be a useful tool to prevent 
subsequent harm. Changes to peripheral oxygen saturation (SpO2) on hypoxic exposure have 
previously been shown to be of poor predictive value. Heart rate variability (HRV) has shown 
promise in the early prediction of AMS, but its use pre-expedition has not previously been 
investigated. We aimed to determine whether pre- and intra-expedition HRV assessment could 
predict susceptibility to AMS at high altitude with better diagnostic accuracy than SpO2.  
 
Methods: 44 healthy volunteers undertook an expedition in the Nepali Himalaya to >5000m. SpO2 
and HRV parameters were recorded at rest in normoxia and in a normobaric hypoxic chamber prior 
to the expedition. The same data were later collected at various altitudes on the expedition along 
with daily Lake Louis Score to assess AMS symptomology.  
 
Results: Low frequency/high frequency ratio (LF/HF) in normoxia and LF following 15 minutes of 
exposure to normobaric hypoxia had moderate (area under the curve ≥ 0.8) diagnostic accuracy. 
LF/HF ratio in normoxia had the highest sensitivity (85%) and specificity (88%) for predicting AMS on 
subsequent ascent to altitude. In contrast pre-expedition SpO2 measurements had poor (area under 
the curve < 0.7) diagnostic accuracy and inferior sensitivity and specificity.  
Conclusions: Pre-ascent measurement of HRV in normoxia has potentially better diagnostic accuracy 
for AMS prediction than all measures of HRV in hypoxia, and better than peripheral SpO2 saturation 
monitoring.  
 Keywords: AMS, altitude, expedition, hypoxia, peripheral oxygen saturation, Heart rate variability. 
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Introduction: 
Acute mountain sickness (AMS) is a complex syndrome presenting at altitudes above 2500m, and 
will affect approximately fifty percent of people above 4000m altitude (Maggiorini et al., 1990). It is 
characterised by headache, gastrointestinal symptoms, fatigue, insomnia, and neurological 
symptoms diagnosed clinically using the Lake Louise Score (Honigman et al., 1993; Lake Louise 
Consensus on the Definition and Quantification of Altitude Illness, 1991). Accurate prediction of AMS 
susceptibility is of importance to enable enhanced prevention measures via increased observation, 
behavioural changes (e.g. slower ascent profile) and/or prophylactic medication. However, a widely-
accepted method for prediction of AMS currently does not exist. 
 
The exact mechanism causing AMS is unknown, but is thought to relate to neurohumoral or 
haemodynamic processes within the central nervous system (Hackett, 1999). Reduced arterial 
oxygen saturation is presumably the ultimate upstream cause and is known to be associated with 
increased reporting of AMS symptoms (Oliver et al., 2012). Nevertheless, participants with similar 
peripheral oxygen saturation (SpO2) may or may not present with AMS (Luks and Swenson, 2011). As 
SpO2 decreases during ascent to high altitude, heart rate increases, presumably as a result of 
increased sympathetic activity and to maintain oxygen delivery (Brierley et al., 2012). Although the 
role of the autonomic nervous system in AMS is poorly understood it is conceivable that autonomic 
dysregulation could play an important role in its genesis (Duplain et al., 1999).  
 
Despite the mechanism of AMS remaining elusive, many authors have attempted to develop tools to 
predict AMS susceptibility. The most commonly investigated tool remains SpO2 monitoring. Current 
evidence suggests that SpO2 values, determined 20–30 min after exposure to hypoxia equivalent to 
2300–4200m, offer the most promise as useful predictors of AMS susceptibility (Burtscher et al., 
2008). Unfortunately, such predictive tools have not shown high diagnostic accuracy and therefore 
have not been widely accepted (Burtscher et al., 2008, Luks and Swenson, 2011). Therefore, 
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alternative or additional measures to improve AMS prediction are of interest. In this regard Burscher 
and colleagues demonstrated a small improvement in AMS prediction when combing SpO2 
monitoring with the blood lactate response to hypoxia (Burtscher et al., 2008), but this invasive 
approach requires technical skills and is time-consuming. If autonomic dysregulation in response to 
hypoxia has a role in the genesis of AMS, then measures of peripheral autonomic activity such as 
heart rate variability (HRV), may provide an alternative additional predictive tool.  
 
 HRV is the beat-to-beat variation in the R-R intervals in an electrocardiogram and it has been 
suggested that it can be used to monitor the activity of the autonomic nervous system (Billman et 
al., 2011). The R-R interval data are analysed and the power of heart rate variability is quantified by 
determining the areas of the spectrum in different component widths: high frequency (HF; 0.15–0.4 
Hz), low frequency (LF; 0.04–0.15 Hz), very low frequency (VLF; ≤ 0.04 Hz) and ultra-low frequency 
(ULF; ≤ 0.0033 Hz) (Camm et al., 1996; Task Force of the European Society of Cardiology and the 
North American Society of Pacing and Electrophysiology, 1996) 
 
HF is widely accepted as an indicator of vagal tone. It is currently considered a good estimator of 
parasympathetic activation of the autonomic nervous system because the sympathetic nervous 
system accounts for only 10% of HF variability (Malliani et al., 1991, Billman, 2013). In contrast, it has 
been suggested that sympathetic and parasympathetic nervous system activation explains roughly 
50% and 25% of the LF variability respectively (De Vito et al., 2002, Shaffer et al., 2014). In addition, 
LF currently is not considered a valid marker of autonomic nervous activity per se as it is influenced 
by the activity of baroreceptors in addition to those of the autonomic nervous system (Billman, 
2013, De Vito et al., 2002, Rahman et al., 2011).  A ratio of LF/HF has also been widely used as an 
indicator of sympatho-vagal balance. Taking into account what is known about LF, the LF/HF ratio 
may be more usefully described as a mutual relationship between baroreflex sensitivity and 
parasympathetic modulation (Rahman et al., 2011, Billman, 2013, Cohen and Taylor, 2002). Finally, a 
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physiological explanation and the mechanism involved in the generation of VLF and ULF have not 
been clarified. Nevertheless, some authors suggest that circadian rhythms, core body temperature, 
metabolism, hormones, and intrinsic rhythms generated by the heart could be the cause of VLF and 
ULF fluctuations (Shaffer et al., 2014). 
 
In clinical settings, HRV has been shown to be useful in post myocardial infarction risk stratification 
and in prediction of anxiety disorders (La Rovere et al., 1998, Chalmers et al., 2014). At altitude, a 
number of studies have investigated the dysregulation of the autonomic nervous system using HRV. 
These studies have shown a transient reduction in parasympathetic and increased sympathetic 
activity during acute exposure to hypobaric hypoxia (Kanai et al., 2001). However, there are few 
studies linking these alterations in the autonomic nervous system with AMS symptoms. Karinen and 
colleagues investigated the potential predictive value of HRV assessed during the actual ascent in 
determining later AMS susceptibility, showing good sensitivity and specificity in diagnosing AMS 
(Karinen et al., 2012), but if HRV is to become a useful applied tool in the prediction and 
management of AMS, its utility in assessment prior to expedition to altitude should be investigated. 
In this regard, Zhang et al. (2014) explored the response of the autonomic system when exposed to 
short term normobaric hypoxia and showed that even on acute short term exposure, a decrease in 
HRV is seen. Taken together the query remains of the possible predictive valve of HRV in normobaric 
hypoxia to predict the development of AMS symptoms on a subsequent expedition to altitude. 
Advances in heart rate telemetry monitoring systems have made it possible to evaluate HRV non-
invasively and in a real-time manner. So, if successful, HRV may offer a low-cost, non-invasive tool to 
help identify those who are at risk of AMS prior to ascent (Burtscher et al., 2004). 
 
The aim of this study was to determine whether HRV assessment prior to (acute normobaric 
normoxia or hypoxia) and during (chronic hypobaric hypoxia) an expedition, could predict 
susceptibility to AMS at high altitude with similar or better diagnostic accuracy to peripheral oxygen 
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desaturation during acute normobaric hypoxia or chronic hypobaric hypoxia. We hypothesised that 
LF, HF and their ratio assessed during 15 minutes of normobaric hypoxia (FiO2 = 11.5%) would have 
acceptable and the best diagnostic accuracy to predict AMS susceptibility, defined as a Lake Louise 
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Materials and methods 
Participants 
The study group consisted of 44 healthy participants (age range 24-62 years; 26 male). Participant 
demographics are provided in table 1. Participants’ maximum living altitude was 450 m and none of 
the participants had been above 3000 m during the month before the expedition. None of the 
participants were taking prophylactic medications for AMS, and none were taking medication known 
to increase HRV (beta-adrenoreceptor antagonists, statins, and angiotensin-converting enzyme 
inhibitors; Bilchick and Berger 2006). All participants gave written informed consent to participate 
and the study was approved by the National Institute for Social Care and Health Research Wales 
Research Ethics Service (14/WA/1260).  
 
Study design 
Baseline data were collected in the laboratories of Bangor University, North Wales (65 m above sea 
level). One month later participants completed an expedition that trekked on foot to a field 
laboratory at 3841 m and on to a maximum altitude of 5085 m (Manaslu circuit in the Nepali 
Himalaya). Participants were divided into five groups in which ascent profiles were essentially similar 
(Figure 1).  
 
Baseline data collection: 
To reduce variability in HRV measures, the participants were required to avoid drinking caffeine, 
alcohol or smoking for at least 12 hours, and to avoid eating and drinking for at least one hour 
before the measurements. Participants presented at the laboratory and were fitted with a 
commercially available heart rate monitor capable of obtaining HRV data (RS800CX, Polar Electro, 
Warwick, UK) and a peripheral oxygen saturation monitor (Onyx II 9550, Nonin, Minnesota, USA). 
Participants first lay supine in normoxia for 15 minutes with their eyes open and were asked to 
breathe normally and regularly. Paced breathing was not required of participants because it was 
8 
  Sutherland et al. 
deemed impractical for clinical settings and is not required to obtain reliable HRV data (Kox et al., 
2011, Kobayashi, 2009). HRV data were collected for the last five minutes as previously 
recommended (Camm et al., 1996) and SpO2 was obtained in the final 30 s. Participants were then 
taken into a hypoxic chamber set at a FiO2 of 11.5% (equivalent to ~ 5000 m) for 15 minutes where 
the protocol above was repeated.  
 
Data collection during ascent:  
Under the supervision of each trekking group’s research lead, participants kept a daily diary of 
various parameters including self-reported AMS symptoms by Lake Louise Score and SpO2 by 
fingertip pulse oximetry (as above). The same time of day, setting (for control of background 
ambient light) and finger was used each day for the measurement of SpO2 and each participant had 
a partner who obtained readings to ensure participants remained blinded to their results. 
Participants had warm hands and obtained measures following overnight fast (Luks and Swenson, 
2011). Preceding the overnight fast (~ 8 hours), normal habitual caffeine intake was allowed. 
 
In addition, at 3841 m the HRV and SpO2 were again obtained using the same data collection 
methods as at baseline but whilst breathing ambient air only.  
 
Data analysis: 
Data processing was performed by Polar Precision Performance software (version 3.02.007) and 
Kubios software (version 2.2) (Tarvainen et al.,2013) An initial examination of the HRV data excluded 
participants from analyses if their data were not considered physiologically plausible, or if the 
tachogram presented evident artifacts exceeding 5% of the total R-R intervals (Dos Santosa et 
al.,2013) (Figure 2). A low-level correction was then applied if the R-R Interval was lower than 0.35 
seconds (refractory time), or R-R intervals that differed more than 20% from the preceding data 
point were detected. If the low-level correction detected more than 5% artifact in the HRV recording 
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then the tachogram was also excluded from analyses (Lippman et al., 1994, Liu et al., 2013, Dos 
Santos et al., 2013, Wessel et al., 2000). 
 
The power spectra were quantified by measuring the area in two frequency bands over a 5-min 
epoch. The LF power was calculated for frequency band 0.04–0.15 Hz and the HF power for 
frequency band 0.15–0.40 Hz. The ratio of LF power to HF power (LF/HF) was also determined. 
 
SpO2 data were expressed as the drop in SpO2 (%) following exposure to hypoxia. AMS was 
diagnosed when participants were above 2500 m and had presence of headache and at least one 
other symptom by Lake Louise Score. These participants were classified as AMS susceptible. 
Participants not meeting these criteria were classified as AMS resistant. Total symptom score was 
also presented.  
 
Statistical analysis: 
Diagnostic accuracy analysis was performed to assess the ability of HRV and SpO2 to predict AMS 
susceptibility during the consequent exposure to altitude. Receiver operating characteristic (ROC) 
curve analysis to predict AMS susceptibility was applied to the HRV data obtained in three different 
environmental conditions: normobaric normoxia and normobaric hypoxia (both obtained at 
baseline) and hypobaric hypoxia (obtained during the trekking ascent at 3841 m). Moreover, ROC 
curve analysis to predict AMS susceptibility was also applied to the drop in SpO2 between normoxia 
and normobaric hypoxia (after 15 minutes, FiO2 = 11.5%) and the drop in SpO2 between normoxia 
and hypobaric hypoxia (after 12 trekking days, 3841 m). All the diagnostic accuracy analyses were 
performed using R 3.2.5 (R Foundation, www.r-project.org). OptimalCutpoint package was installed 
in R and it was used to obtain the area under ROC curve (AUC), the optimal cutpoint, the sensitivity, 
the specificity and the ROC curve plots (López-Ratón and Rodríguez-Álvarez, 2014). Epi and pROC 
packages were also installed in R and used to confirm the results concerning AUC generated by the 
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OptimalCutpoint package. As results were the same only data from the OptimalCutpoint package is 
presented herein. The pROC package was also used to calculate the confidence intervals (CI) of the 
AUC. An AUC greater than 0.7 was considered fair; an AUC greater than 0.8 was considered 
moderate (Obuchowski et al., 2004); in both cases it was required that the 95% CI was greater than 
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Results: 
 
Of the 44 participants recruited at the beginning of the study, 28 provided acceptable HRV, SpO2 and 
AMS data at all required time points. Therefore, only the data regarding these participants has been 
used for the data analysis and statistical analysis. The flow of participants through the study is shown 
in Figure 2. The mean HRV and SpO2 response to the various environmental conditions is shown in 
table 2 and the individual responses for selected variables is shown in Figure 3. 
 
During the expedition 20 of the 28 participants showed AMS symptoms, giving an AMS incidence of 
71.4%. The length of time with AMS was mean (SD) 3.85 (2.23) days. Participants who presented 
with clinically defined AMS reported a total accumulative symptom score of 30.3 (14.5); participants 
who didn’t present with clinically defined AMS reported a total accumulative symptom score of 12.3 
(6.4). 
 
Of the nine HRV predictor variables considered in this study, three variables presented fair 
diagnostic accuracy to predict AMS susceptibility (normoxia LF, chronic hypobaric hypoxia ratio and 
chronic hypobaric hypoxia LF) and two presented moderate diagnostic accuracy (normoxia ratio and 
acute normobaric hypoxia LF) (table 3). Of these two moderately accurate predictors, the normoxia 
ratio had the best diagnostic accuracy, having a higher AUC (0.88 vs. 0.80) and better sensitivity and 
specificity, correctly identifying 85% of true positives (AMS susceptible participants) and 88% of true 
negatives (AMS resistant participants) (figure 4). Notably, LF had better diagnostic accuracy than HF 
in all environmental conditions, having AUC values greater than 0.7 (AUC of the HF variables were all 
lower than 0.7). Moreover, LF showed similar or better sensitivity and specificity than HF. In 
contrast, SpO2 variables considered in this study showed a poor diagnostic accuracy (AUC < 0.7) with 
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Discussion: 
The aim of this study was to assess the diagnostic accuracy of pre- and intra-expedition HRV and 
SpO2 measurements to predict AMS susceptibility at high altitude. 
The study’s main findings were that LF/HF ratio in normoxia and LF following 15 minutes of exposure 
to normobaric hypoxia are promising variables to predict AMS during subsequent altitude exposure, 
showing moderate diagnostic accuracy (AUC greater than 0.8). Surprisingly, LF/HF ratio in normoxia 
had the best diagnostic accuracy (having the highest AUC), and the best sensitivity (85%) and 
specificity (88%) of all predictors. Three other variables had fair diagnostic accuracy (AUC greater 
than 0.7) to predict AMS susceptibility: normoxia LF, chronic hypobaric hypoxia ratio and chronic 
hypobaric hypoxia LF. Generally, LF band HRV had better diagnostic accuracy than HF bands. In 
contrast, fall in SpO2 following 15 minutes of exposure to normobaric hypoxia or following 12 days 
exposure to hypobaric hypoxia had poor diagnostic accuracy (AUC less than 0.7).  
We further found that at rest in normobaric normoxia, the mean LF/HF ratio was higher in the group 
of participants who did not subsequently develop AMS than in those who developed AMS. Despite 
this finding and the generally better diagnostic accuracy for this parameter compared to change in 
SpO2, scatterplots of individual data reveal there is still significant overlap of data points for LF/HF 
ratio between the AMS and non-AMS groups (Figure 3). 
Heart Rate Variability  
The relationship between hypoxia and HRV is complex, and thus it is unsurprising that there are 
inconsistent results in the literature (Loeppky et al., 2003; Lanfranchi et al., 2005; Chen et al., 2008; 
Huang et al., 2010; Karinen et al., 2012; Koehle et al., 2010; Wille et al., 2012; Mairer et al., 2013). 
Generally, hypoxia is thought to potently stimulate the sympathetic nervous system, causing a 
reduction of HRV variability (LF and HF components) and an increase in the LF/HF ratio (Zhang et al., 
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2014). The results reported herein are consistent with this commonly observed response to hypoxia, 
showing a reduction in heart rate variability upon acute exposure that was somewhat normalised 
with chronic exposure.  
The present study extends previous findings by identifying that an LF/HF ratio of less than 2.28 a.u. 
in normoxia could identify with reasonable diagnostic accuracy AMS-susceptibility. The only other 
study to have described risks of developing AMS by using a HRV cutoff is by Huang et al. (2010), who 
found a 7-fold increase in the odds of developing AMS in participants with an LF/HF ratio greater 
than 1.3 a.u. measured at 1317m. Although the present results do not concur with this finding, the 
measurements in Huang et al.’s study were taken in field conditions and were used to predict AMS 
at moderate altitude (3440 m). In contrast the present data were taken pre-expedition and were 
used to predict AMS at a much higher altitude (5085 m). Comparisons between the present and 
previous studies are also difficult because of differences in data analysis. For example, to our 
knowledge, this is the first study to have employed strict a priori-agreed exclusion criteria regarding 
implausible data and artefact, and the first study to include a diagnostic accuracy analysis to 
determine performance of HRV data obtained pre-expedition to predict AMS susceptibility.  
In the present study, LF/HF ratio in normoxia had the best diagnostic accuracy, whilst the LF band 
demonstrated better diagnostic accuracy than HF under all conditions. As the mechanisms 
underlying HRV are complex, the exact physiological explanation of these findings are unclear. The 
traditional understanding that LF and HF components reflect sympathetic and parasympathetic 
activity, respectively, is now seen as overly simplistic (Scheff et al., 2014). It has recently been 
appreciated that other important factors in modulating HRV are mechanoreceptors and ventilatory 
response (Scheff et al., 2014), and that autonomic changes that affect heart rate tend to alter both 
LF and HF components (Chiu et al., 2003). Nevertheless it is tempting to speculate that since LF/HF 
ratio and LF take into account both sympathetic and parasympathetic cardiac supply, and may be 
related to baroreflex function, these HRV variables are better overall reflections of baroreflex 
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activity, cardiac tone and sympatho-vagal balance (De Vito et al., 2002, Shaffer et al., 2014). 
Hence their performance to predict AMS susceptibility may be superior because they reflect 
the interaction of multiple physiological factors that cause AMS.  
A surprising finding was the superior diagnostic accuracy of measurements taken in normoxia 
compared to hypoxia. Many studies have considered pre-expedition measurements in hypoxia to be 
a proxy for hypoxic conditions at true altitude, but it may be that individuals’ physiological response 
to prolonged hypoxia, when given time to acclimatize, is different to acute hypoxic exposure. In this 
regard Zhang et al. (2014) found a significant increase in cardiorespiratory phase synchronization on 
exposure to acute hypoxia, which was associated with a lower HRV. Thus, variable ventilatory 
responses to acute hypoxia may confound the measurements of HRV if also obtained in acute 
hypoxia.  
A further problem when comparing studies is that models of the effect of altitude on the autonomic 
nervous system often only consider the hypoxia variable, although both temperature and barometric 
pressure may have an independent effect on physiology at altitude (Conkin and Wessel, 2008; 
Coppel et al., 2015). Moreover, AMS symptoms can be less severe in normobaric hypoxia (Roach et 
al., 1996). Interestingly, the present finding that the best predictor for subsequent AMS is LF/HF 
ratio in normobaric normoxia suggests there are physiological differences between AMS-susceptible 
and AMS– resistant individuals that are observable even at sea level. The protective nature of a high 
HRV and a sympathovagal balance shifted to sympathetic dominance may be protective per se, or 
may reflect some other parameter, such as physical fitness or autonomic activity responsiveness, in 
particular to stressors such as hypoxia. Other ‘sea level’ physiological differences have been 
demonstrated previously, such as gag reflex (Austin and Sleigh, 1995) and resting blood pressure 
(Lanfranchi et al., 2005). In support of our findings, Akselrod et al. (2001) found that individuals with 
higher baseline autonomic activity were more resistant to desaturation on exposure to acute 
hypoxia. Although a recent study by Botek et al. (2015) found no correlation between the LF/HF ratio 
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and delta SpO2, it was not determined whether LF/HF ratio or delta SpO2 predicted subsequent AMS, 
so the lack of correlation may reveal the poor predictive value and the variable nature of the SpO2 
response to acute hypoxia (rather than invalidating HRV measurements for field use).  
Oxygen saturations  
Measurement of SpO2 at rest has previously been proposed as an indicator for inadequate 
acclimatization (Karinen et al., 2010), with several studies finding an inverse relationship between 
SpO2 and AMS-susceptibility (Mairer et al., 2013, Karinen et al., 2010). More severe desaturation in 
hypoxia in AMS-susceptible participants is probably due to differences in ventilatory response 
(Burtscher et al., 2004) or a ventilation/perfusion mismatch (Loeppky et al, 2008). However, 
measurement of SpO2 for 15 minutes in acute normobaric hypoxia and chronic hypobaric hypoxia in 
the present study showed poor diagnostic accuracy. Indeed, other studies have found no association 
(Wille et al., 2012). Although some authors have proposed that inconsistencies may be due to 
differences in the time of measurement (SpO2 measured after >20 minutes in hypoxia, but within 
the first hour, appears to have superior predictive value than later measurements (Burtscher et al., 
2008, Loeppky et al., 2008)), it is an unlikely explanation in the present study because data were also 
taken after chronic exposure to hypobaric hypoxia, and still showed poor diagnostic accuracy. It is 
conceivable that the peripheral oxygen saturation method may be unreliable, even though the 
present methodology was standardised and likely to be more reliable than if used outside of the 
research setting.  
Strengths and limitations of the study 
The rate of ascent and previous acclimatization can affect the likelihood of developing AMS (Bartsch 
and Saltin, 2008). The ascent profiles for all participant groups were similar and all participants 
climbed the same route (Figure 1). None of the participants had been to altitude within the month 
proceeding the expedition. All data was collected at the same time after reaching a given altitude 
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with control of variables such as caffeine, smoking and eating prior to collection of HRV data. We 
also gave advice to ensure participants stayed well hydrated during the expedition. Thus, many of 
the variables that can influence AMS and HRV were well controlled (enhancing internal validity). We 
note that uncontrolled variables such as age and sex can influence HRV, however the outcome 
measure of AMS was obtained in the field in a group of heterogeneous participants representative 
of typical high altitude sojourners (enhancing external validity). We have also provided detailed 
explanation of the criterion used to exclude HRV data due to artefact or physiologically implausible 
data. Combined with the use of diagnostic accuracy statistics and individual data plots, the study 
thus allows a meaningful interpretation of the utility of HRV at different time points (before or 
during the expedition) to predict AMS.  
A major concern regarding use of HRV to predict AMS susceptibility is that of 35 complete data sets, 
6 participants’ data had to be excluded due to artefacts or implausible data (Figure 2), despite 
controls such as lying still and not talking. Thus, until the data collection equipment is improved or 
simplified, there will be participants for whom prediction of AMS susceptibility is currently not 
possible. It is also possible that HRV simply reflects some other unidentified predictor of AMS (but 
exploratory analyses of other independent variables could not identify any such predictor). 
Finally, it is well known that respiratory rate effects heart rate variability and peripheral oxygen 
saturations.  Bilman (2011) discussed the effect of respiratory parameters on heart rate variability, 
suggesting that both respiratory rate and tidal volume alter heart rate variability, including both the 
HF and LF components. Lehrer and Gevirtz (Lehrer and Gevirtz, 2014) suggest that a respiratory rate 
between 4.5 and 7 breaths per minute improves autonomic homeostasis via heart rate variability  
biofeedback. They further suggest that breathing at the rate of the cardiovascular systems 
resonance frequency can enhance performance. However, respiratory rate is grossly effected by 
altitude (Richard et al., 2014); controlling and thus changing a participant’s respiratory rate would 
not reflect their physiological state during the rest of the expedition. Furthermore, it is practical to 
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control respiratory rate in normobaric normoxia, but may be impossible to control respiratory rate in 
normobaric or hypobaric hypoxia. Instead, we told participants to lie awake and breath normally, 
thus avoiding periodic breathing. As for peripheral oxygen saturations, some variability in this 
measure will have arisen due to using only acute exposure to normobaric hypoxia. Such variability 
may lead to an underestimation of the diagnostic accuracy of SpO2. However, previous observations 
by our group suggest this variability is considerably reduced at 15 minutes compared to initial 
exposure. Thus for both heart rate variability and peripheral oxygen saturation we chose to make a 
compromise between scientific rigor and practically implementable methods that would most likely 
be adopted in the field. 
Implications for practice  
In the present study, an accurate predictor for AMS susceptibility was identified using a simple tool 
implementable at sea level. This is important, because for a diagnostic tool for AMS to be clinically 
useful, results must be available in time to make adjustments to prevent disease. For example, 
lengthening the ascent profile, or taking prophylactic mediation. A recent study by Karinen et al. 
(2012) found root mean square differences of HRV at 2400m had 92% sensitivity for detecting AMS if 
ascent continued to 3000-4300m without acclimatization. However, the need for a field laboratory 
and technicians at 2400m, at which point some individuals may already be suffering from AMS 
(Burtscher et al., 2008) and from which altitude it may be too late to change itinerary, make these 
measurements unwieldy and unsuitable as methods of predicting disease (Song et al., 2013). Even 
studies finding potentially clinically useful pre-expedition predictors usually require long exposure to 
simulated altitude (Mairer et al., 2013), which is demanding on time, technology, and finances.  
LF/HF ratio of less than 2.28 in normoxia was recognized as being the best cutpoint to identify 
individuals at risk of AMS during altitude exposure. This has interesting practical implications 
because it suggests that hypoxic exposure pre-expedition may not be required to predict AMS 
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susceptibility. This finding is consistent with the results of Rossetti et al. (2016; in press), who found 
that normoxic VO2 max predicts altitude performance without measures of hypoxic sensitivity. Our 
findings also give an insight into cardiac autonomic responses in regard to AMS development and 
might help to clarify the question of whether HRV modulations appear as a consequence and/or 
cause of AMS.   
Currently, however, post-processing of the HRV data is still required, making interpretations of the 
results difficult without some technical knowledge. Also until equipment is improved, any HRV test 
should last at least 10 minutes, to allow for removal of artefact from the recording. Modification of 
existing heart rate monitors should be considered, to give information to users pre-expedition on 
their susceptibility to AMS at true altitude, by measuring LF/HF ratio in normoxia. A simple 
diagnostic test incorporated into a watch has the potential to reduce AMS by allowing 
implementation of preventative measures, but should be used with caution to prevent participants 
who are predicted to be AMS resistant from ignoring general advice on AMS prevention.  Finally, at 
present some overlap in HRV responses between AMS susceptible and AMS resistant individuals 
exists. Therefore, further research is needed to validate our findings with an increased number of 
more heterogeneous participants, of varying degrees of AMS, to determine the true utility of HRV 
data to predict AMS.   
 
Conclusion 
This study showed that HRV has better diagnostic accuracy for AMS prediction than peripheral SpO2 
saturation monitoring. These results show the measurement with the highest diagnostic accuracy is 
normoxic LF/HF ratio, measured pre-expedition. Further confirmatory studies are needed to validate 
these measurements, but they suggest an alternative approach to obtain a more accurate, simple 
method of predicting AMS.  
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Table legends. 
Table 1. Participant demographics. 
 
 Participants included: Participants excluded: 
 Male Female Male Female 
Gender (n) 17 11 9 7 
   
 Mean SD Mean SD 
Age (y) 34.0 12.7 42.9 13.4 
Height (cm) 172 10 171 10 
Body mass (Kg) 66.3 12.0 70.9 13.6 
VO2max (ml/kg/min) 46.69 6.02 44.50 9.66 
Living altitude (m) 74 118 85 100 
Days mountaineering (n) 9 12 5 9 
Physical activity score (a.u) 5.3 1.5 4.2 2.5 
     
 Participants included: Participants excluded: 
 Yes Yes  
AMS susceptible on the expedition (n) 20 6 
Previous experience of acute mountain 
sickness (n) 20 13 
Previous experience of high altitude 
pulmonary oedema (n) 1 0 
Previous experience of high altitude 
cerebral oedema (n) 0 0 
Smoker (n) 1 1 
Consumes alcohol (n) 27 15 
History of headache/migraine (n) 3 5 
Consumes dietary supplement 2 3 
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Table 2. Heart rate variability response and peripheral oxygen saturation response to hypoxic 
exposure assessed before and during a high altitude expedition. HRV heart rate variability; LF low 
frequency; HF high frequency; Δ SpO2, drop in peripheral oxygen saturation between normoxia and 
hypoxia. 
 
Environmental condition  Variable Mean SD 
After 15 min exposure to 
normobaric normoxia  
HRV ratio (a.u.) 1.99  1.35  
HRV LF (ms2) 1380 1096 
HRV HF (ms2) 1088 1953 
After 15 min exposure to 
normobaric hypoxia 
HRV ratio (a.u.) 3.91  3.13  
HRV LF (ms2) 1031 845 
HRV HF (ms2) 347 273 
Δ SpO2 (%) 21.1 7.2 
After 12 days exposure to 
hypobaric hypoxia 
HRV ratio (a.u.) 2.78 3.44  
HRV LF (ms2) 1246 1604 
HRV HF (ms2) 763 974 
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Table 3. Diagnostic accuracy of heart rate variability assessed before and during a high altitude 
expedition to determine susceptibility to Acute Mountain Sickness. HRV heart rate variability; LF low 














After 15 min exposure 
to normobaric 
normoxia  
Ratio 0.875 (0.741-1,000) 85 87.5 ≤2.28 a.u. 
LF 0.781 (0.591-0.972) 75 75 >552 ms2 
HF 0.506 (0.235-0.753) 50 55 >1252 ms2 
After 15 min exposure 
to normobaric hypoxia 
Ratio 0.638 (0.380-0.895) 70 62.5 ≤3.13 a.u. 
LF 0.800 (0.627-0.973) 70 75 >275 ms2 
HF 0.694 (0.424-0.963) 70 75 >740 ms2 
After 12 days 
exposure to 
hypobaric hypoxia 
Ratio 0.731 (0.532-0.931) 70 75 ≤1.91 a.u. 
LF 0.725 (0.503-0.947) 80 62.5 >276 ms2 
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Table 4. Diagnostic accuracy of peripheral oxygen desaturation assessed before and during a high 
altitude expedition to determine susceptibility to Acute Mountain Sickness. AUC (CI) area under 










After 15 min exposure 
to normobaric hypoxia 
0.688 (0.478-0.897) 65 75 >21 % 
After 12 days 
exposure to hypobaric 
hypoxia 
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Figure 3: Individual responses to hypoxic exposure for selected HRV and SpO2 variables assessed 
before and during a high altitude expedition. HRV heart rate variability; LF low frequency; HF high 
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Figure 4: Receiver operating characteristic curve for selected heart rate variability and peripheral 
oxygen desaturation variables assessed before a high altitude expedition to determine susceptibility 
to Acute Mountain Sickness. LF low frequency; SpO2 drop in peripheral oxygen saturation between 
normoxia and normobaric hypoxia 
 
 
 
 
 
 
 
 
